Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application (Q39633680)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 3, 2010

Language	Label	Description	Also known as
English	Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application	scientific article published on December 3, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer drug-resistance and a look at specific proteins: Rho GDP-dissociation inhibitor 2, Y-box binding protein 1, and HSP70/90 organizing protein in proteomics clinical application (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application (English)

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

antineoplastic resistance

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21067243

24 August 2024

drug resistance

1 reference

based on heuristic

inferred from title

4

object named as

Petr Halada

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21067243

24 August 2024

Marián Hajdúch

6

object named as

Marian Hajduch

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21067243

24 August 2024

author name string

Helena Skalnikova

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jirina Martinkova

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Rita Hrabakova

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Marta Dziechciarkova

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Suresh Jivan Gadher

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Andreas Hammar

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Daniel Enetoft

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Andreas Ekefjard

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ola Forsstrom-Olsson

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hana Kovarova

12

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21067243

24 August 2024

publication date

3 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://pubs.acs.org/doi/pdf/10.1021/pr100468w

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Journal of Proteome Research

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

404-415

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Resistance to chemotherapy: new treatments and novel insights into an old problem

1

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment

2

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Tumour stem cells and drug resistance

3

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine

5

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

General Articles Perspectives on Cancer Therapy: Cell Cycle Blockers and Perturbators

6

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

8

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry.

9

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry

10

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response

12

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases.

14

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Hop: more than an Hsp70/Hsp90 adaptor protein

15

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Identification of molecular targets for selective elimination of TRAIL-resistant leukemia cells. From spots to in vitro assays using TOP15 charts.

16

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins.

17

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Cancer Research

19

62

6418

author name string

Gildea J. J.

publication date

2002

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

20

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

21

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Changes in gene expression during progression of ovarian carcinoma

22

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells

24

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer

25

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Comparative Proteomics Analysis of Barrett Metaplasia and Esophageal Adenocarcinoma Using Two-dimensional Liquid Mass Mapping

26

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.

30

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

32

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.

33

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.

34

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins

35

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases

36

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Nuclear translocation of the phosphoprotein Hop (Hsp70/Hsp90 organizing protein) occurs under heat shock, and its proposed nuclear localization signal is involved in Hsp90 binding

38

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant

39

1 reference

10.1021/PR100468W

https://api.crossref.org/works/10.1021/PR100468W

24 August 2024

Identifiers

10.1021/PR100468W

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39633680&oldid=2249182289"